Down Regulation of CIAPIN1 Reverses Multidrug Resistance in Human Breast Cancer Cells by Inhibiting MDR1

Cytokine-induced apoptosis inhibitor 1 (CIAPIN1), initially named anamorsin, a newly indentified antiapoptotic molecule is a downstream effector of the receptor tyrosine kinase-Ras signaling pathway. Current study has revealed that CIAPIN1 may have wide and important functions, especially due to its close correlations with malignant tumors. However whether or not it is involved in the multi-drug resistance (MDR) process of breast cancer has not been elucidated. To explore the effect of CIAPIN1 on MDR, we examined the expression of P-gp and CIAPIN1 by immunohistochemistry and found there was positive correlation between them. Then we successfully interfered with RNA translation by the infection of siRNA of CIAPIN1 into MCF7/ADM breast cancer cell lines through a lentivirus, and the expression of the target gene was significantly inhibited. After RNAi the drug resistance was reduced significantly and the expression of MDR1mRNA and P-gp in MCF7/ADM cell lines showed a significant decrease. Also the expression of P53 protein increased in a statistically significant way (p ≤ 0.01) after RNAi exposure. In addition, flow cytometry analysis reveals that cell cycle and anti-apoptotic enhancing capability of cells changed after RNAi treatment. These results suggested CIAPIN1 may participate in breast cancer MDR by regulating MDR1 and P53 expression, changing cell cycle and enhancing the anti-apoptotic capability of cells.

[1]  Xiaohua Li,et al.  CIAPIN1 inhibits the growth and proliferation of clear cell renal cell carcinoma. , 2009, Cancer letters.

[2]  B. Schnierle,et al.  Selective gene silencing by viral delivery of short hairpin RNA , 2010, Virology Journal.

[3]  H. Ahsan,et al.  Sanguinarine induces apoptosis of human pancreatic carcinoma AsPC-1 and BxPC-3 cells via modulations in Bcl-2 family proteins. , 2007, Cancer letters.

[4]  H. Lage.  An overview of cancer multidrug resistance: a still unsolved problem , 2008, Cellular and Molecular Life Sciences.

[5]  Xiaohua Li,et al.  CIAPIN1 confers multidrug resistance by upregulating the expression of MDR-1 and MRP-1 in gastric cancer cells , 2006, Cancer biology & therapy.

[6]  C. Boetes,et al.  Update on screening breast MRI in high-risk women. , 2010, Magnetic resonance imaging clinics of North America.

[7]  H. Kim,et al.  Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  Ning Li,et al.  CIAPIN1 confers multidrug resistance through up-regulation of MDR-1 and Bcl-L in LoVo/Adr cells and is independent of p53. , 2011, Oncology reports.

[9]  X. Gu,et al.  Direct assessment of P-glycoprotein efflux to determine tumor response to chemotherapy. , 2010, Biochemical pharmacology.

[10]  I. Song,et al.  Induction of apoptosis in colon cancer cells by a novel topoisomerase I inhibitor TopIn. , 2011, Biochemical and biophysical research communications.

[11]  F. Liu,et al.  The effect of survivin on multidrug resistance mediated by P-glycoprotein in MCF-7 and its adriamycin resistant cells. , 2007, Biological & pharmaceutical bulletin.

[12]  John F. G. Atack,et al.  RNA Interference , 2010, Methods in Molecular Biology.

[13]  J. Roh,et al.  P-glycoprotein: The intermediate end point of drug response to induction chemotherapy in locally advanced breast cancer , 2004, Breast Cancer Research and Treatment.

[14]  J. Hughes,et al.  In vitro cytotoxic activity of cationic paclitaxel nanoparticles on MDR-3T3 cells , 2010, Journal of drug targeting.

[15]  R. Rosenfeld.  Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[16]  Xiaohua Li,et al.  A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax. , 2007, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[17]  Shiaw-Yih Lin,et al.  siRNA-Based Targeting of Cyclin E Overexpression Inhibits Breast Cancer Cell Growth and Suppresses Tumor Development in Breast Cancer Mouse Model , 2010, PloS one.

[18]  Xiaojing Ma,et al.  Regulation of IL-27 p28 gene expression in macrophages through MyD88- and interferon-γ–mediated pathways , 2007, The Journal of experimental medicine.

[19]  E. Morii,et al.  Identification of a Cytokine-induced Antiapoptotic Molecule Anamorsin Essential for Definitive Hematopoiesis , 2004, The Journal of experimental medicine.

[20]  M. Hino,et al.  The expression of anamorsin in diffuse large B cell lymphoma: Possible prognostic biomarker for low IPI patients , 2008, Leukemia & lymphoma.

[21]  Xiaohua Li,et al.  Downregulated expression of CIAPIN1 may contribute to gastric carcinogenesis by accelerating cell proliferation and promoting cell cycle progression , 2009, Cancer biology & therapy.

[22]  M. Taheri,et al.  Effect of MDR1 polymorphism on multidrug resistance expression in breast cancer patients. , 2010, Genetics and molecular research : GMR.

[23]  I. Tannock,et al.  Global drug development in cancer: A cross-sectional study of clinical trial registries. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  U. Gündüz,et al.  Reversal of multidrug resistance by small interfering RNA (siRNA) in doxorubicin-resistant MCF-7 breast cancer cells. , 2011, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[25]  D. Ma,et al.  Knock-down of P-glycoprotein reverses taxol resistance in ovarian cancer multicellular spheroids. , 2007, Oncology reports.

[26]  V. Rotter,et al.  p53-dependent cell cycle control: response to genotoxic stress. , 1998, Seminars in cancer biology.

[27]  C. Henderson,et al.  Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS , 2005, Nature Medicine.

[28]  Jie Liu,et al.  [CIAPIN1 expression in human lung cancer tissues and inhibitory effects of the gene on human pulmonary carcinoma NCI-H446 cells]. , 2008, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology.

[29]  Y. Xiang,et al.  Cancer survival in Shanghai, China, 1992-1995. , 2011, IARC scientific publications.

[30]  Sushama Talegaonkar,et al.  Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation. , 2009, Drug discovery today.

[31]  M. Fukuzawa,et al.  Increased expression of multidrug resistance-associated genes after chemotherapy in pediatric solid malignancies. , 2009, Journal of pediatric surgery.

[32]  C. Schmidt,et al.  The Role of Nuclear Factor &kgr;B in Pancreatic Cancer and the Clinical Applications of Targeted Therapy , 2008, Pancreas.

[33]  Xiaohua Li,et al.  Distribution of CIAPIN1 in Normal Fetal and Adult Human Tissues , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[34]  Shuang-yin Han,et al.  Adenovirus-delivered CIAPIN1 small interfering RNA inhibits HCC growth in vitro and in vivo , 2008, Carcinogenesis.

[35]  J. Molnár,et al.  Interaction of tomato lectin with ABC transporter in cancer cells: glycosylation confers functional conformation of P-gp. , 2009, Acta histochemica.

[36]  L. O’Driscoll,et al.  Expression of multidrug resistance markers ABCB1 (MDR-1/P-gp) and ABCC1 (MRP-1) in renal cell carcinoma , 2009, BMC urology.

[37]  M. Kuo,et al.  Roles of multidrug resistance genes in breast cancer chemoresistance. , 2007, Advances in experimental medicine and biology.

[38]  Y. Kawakami,et al.  The RNA silencing technology applied by lentiviral vectors in oncology. , 2010, Methods in molecular biology.

[39]  G. Peters,et al.  Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models , 2010, Investigational New Drugs.

[40]  Xiaohua Li,et al.  CIAPIN1 inhibits gastric cancer cell proliferation and cell cycle progression by downregulating cyclyinD1 and upregulating p27 , 2007, Cancer biology & therapy.

[41]  Brian Davis,et al.  Generation of a packaging cell line for prolonged large‐scale production of high‐titer HIV‐1‐based lentiviral vector , 2005, The journal of gene medicine.